| Year |
Citation |
Score |
| 2020 |
Mantegazza R, O'Brien FL, Yountz M, Howard JF. Consistent improvement with eculizumab across muscle groups in myasthenia gravis. Annals of Clinical and Translational Neurology. PMID 32700461 DOI: 10.1002/Acn3.51121 |
0.407 |
|
| 2020 |
Areson DG, Filer WG, Harris MG, Howard JF, Shuping LT, Traub R. Accuracy of the Scratch Collapse Test for Carpal Tunnel Syndrome in Comparison With Electrodiagnostic Studies. Hand (New York, N.Y.). 1558944719895786. PMID 32698624 DOI: 10.1177/1558944719895786 |
0.313 |
|
| 2020 |
Albazli K, Kaminski HJ, Howard JF. Complement Inhibitor Therapy for Myasthenia Gravis. Frontiers in Immunology. 11: 917. PMID 32582144 DOI: 10.3389/Fimmu.2020.00917 |
0.339 |
|
| 2020 |
Jacob S, Murai H, Utsugisawa K, Nowak RJ, Wiendl H, Fujita KP, O'Brien F, Howard JF. Response to eculizumab in patients with myasthenia gravis recently treated with chronic IVIg: a subgroup analysis of REGAIN and its open-label extension study. Therapeutic Advances in Neurological Disorders. 13: 1756286420911784. PMID 32426038 DOI: 10.1177/1756286420911784 |
0.335 |
|
| 2020 |
Vissing J, Jacob S, Fujita KP, O'Brien F, Howard JF. 'Minimal symptom expression' in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab. Journal of Neurology. PMID 32189108 DOI: 10.1007/S00415-020-09770-Y |
0.3 |
|
| 2020 |
Howard JF, Nowak RJ, Wolfe GI, Freimer ML, Vu TH, Hinton JL, Benatar M, Duda PW, MacDougall JE, Farzaneh-Far R, Kaminski HJ, Barohn R, Dimachkie M, Pasnoor M, ... ... Howard JF, et al. Clinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in Patients With Moderate to Severe Generalized Myasthenia Gravis: Results of a Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial. Jama Neurology. PMID 32065623 DOI: 10.1001/Jamaneurol.2019.5125 |
0.331 |
|
| 2019 |
Howard JF, Bril V, Burns TM, Mantegazza R, Bilinska M, Szczudlik A, Beydoun S, Garrido FJRR, Piehl F, Rottoli M, Van Damme P, Vu T, Evoli A, Freimer M, Mozaffar T, et al. Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis. Neurology. PMID 31118245 DOI: 10.1212/Wnl.0000000000007600 |
0.3 |
|
| 2019 |
Andersen H, Mantegazza R, Wang JJ, O'Brien F, Patra K, Howard JF. Eculizumab improves fatigue in refractory generalized myasthenia gravis. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. PMID 30905021 DOI: 10.1007/S11136-019-02148-2 |
0.303 |
|
| 2018 |
Clifford KM, Hobson-Webb LD, Benatar M, Burns TM, Barnett C, Silvestri NJ, Howard JF, Visser A, Crum BA, Nowak R, Beekman R, Kumar A, Ruzhansky K, Chen IA, Pulley MT, et al. Thymectomy may not be associated with clinical improvement in MuSK myasthenia gravis. Muscle & Nerve. PMID 30575980 DOI: 10.1002/Mus.26404 |
0.394 |
|
| 2018 |
Li Y, Guptill JT, Russo MA, Massey JM, Juel VC, Hobson-Webb LD, Howard JF, Chopra M, Liu W, Yi JS. Tacrolimus inhibits Th1 and Th17 responses in MuSK-antibody positive myasthenia gravis patients. Experimental Neurology. PMID 30472069 DOI: 10.1016/J.Expneurol.2018.11.006 |
0.304 |
|
| 2018 |
Moore CJ, Caughey MC, Meyer DO, Emmett R, Jacobs C, Chopra M, Howard JF, Gallippi CM. In Vivo Viscoelastic Response (VisR) Ultrasound for Characterizing Mechanical Anisotropy in Lower-Limb Skeletal Muscles of Boys with and without Duchenne Muscular Dystrophy. Ultrasound in Medicine & Biology. PMID 30174231 DOI: 10.1016/J.Ultrasmedbio.2018.07.004 |
0.398 |
|
| 2018 |
Howard JF, O'Brien F, Wang JJ. Distinct representation of muscle weakness in QMG and MG-ADL - Authors' reply. The Lancet. Neurology. 17: 205-206. PMID 29452680 DOI: 10.1016/S1474-4422(18)30036-X |
0.398 |
|
| 2017 |
Howard JF. Myasthenia gravis: the role of complement at the neuromuscular junction. Annals of the New York Academy of Sciences. PMID 29266249 DOI: 10.1111/Nyas.13522 |
0.409 |
|
| 2017 |
Howard JF, Utsugisawa K, Benatar M, Murai H, Barohn RJ, Illa I, Jacob S, Vissing J, Burns TM, Kissel JT, Muppidi S, Nowak RJ, O'Brien F, Wang JJ, Mantegazza R, et al. Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study. The Lancet. Neurology. PMID 29066163 DOI: 10.1016/S1474-4422(17)30369-1 |
0.31 |
|
| 2017 |
Benatar M, Howard JF, Barohn R, Wolfe GI, Cutter G. Learning from the past: reflections on recently completed myasthenia gravis trials. Annals of the New York Academy of Sciences. PMID 29064567 DOI: 10.1111/Nyas.13501 |
0.317 |
|
| 2017 |
Hehir MK, Hobson-Webb LD, Benatar M, Barnett C, Silvestri NJ, Howard JF, Howard D, Visser A, Crum BA, Nowak R, Beekman R, Kumar A, Ruzhansky K, Chen IA, Pulley MT, et al. Rituximab as treatment for anti-MuSK myasthenia gravis: Multicenter blinded prospective review. Neurology. PMID 28801338 DOI: 10.1212/Wnl.0000000000004341 |
0.378 |
|
| 2017 |
Guglieri M, Bushby K, McDermott MP, Hart KA, Tawil R, Martens WB, Herr BE, McColl E, Wilkinson J, Kirschner J, King WM, Eagle M, Brown MW, Willis T, Hirtz D, ... ... Howard JF, et al. Developing standardized corticosteroid treatment for Duchenne muscular dystrophy. Contemporary Clinical Trials. PMID 28450193 DOI: 10.1016/J.Cct.2017.04.008 |
0.308 |
|
| 2017 |
Richards J, Howard JF. Seronegative myasthenia gravis associated with malignant thymoma. Neuromuscular Disorders : Nmd. PMID 28238572 DOI: 10.1016/J.Nmd.2017.01.023 |
0.362 |
|
| 2016 |
Howard JF, Freimer M, O'Brien F, Wang JJ, Collins SR, Kissel JT, Herbelin L, McVey AL, Dimachkie MM, Pasnoor M, Lu D, Waltz A, Chaudhry V, Corse A, et al. QMG and MG-ADL Correlations: Study of Eculizumab Treatment of Myasthenia Gravis. Muscle & Nerve. PMID 28010051 DOI: 10.1002/Mus.25529 |
0.308 |
|
| 2016 |
Guptill JT, Juel VC, Massey JM, Anderson AC, Chopra M, Yi JS, Esfandiari E, Buchanan T, Smith B, Atherfold P, Jones E, Howard JF. Effect of therapeutic plasma exchange on immunoglobulins in myasthenia gravis. Autoimmunity. 1-8. PMID 27684107 DOI: 10.1080/08916934.2016.1214823 |
0.336 |
|
| 2016 |
Pasnoor M, He J, Herbelin L, Burns TM, Nations S, Bril V, Wang AK, Elsheikh BH, Kissel JT, Saperstein D, Shaibani JA, Jackson C, Swenson A, Howard JF, Goyal N, et al. A randomized controlled trial of methotrexate for patients with generalized myasthenia gravis. Neurology. PMID 27306628 DOI: 10.1212/Wnl.0000000000002795 |
0.311 |
|
| 2015 |
Beltran Papsdorf T, Howard JF, Chahin N. Late-onset Becker muscular dystrophy: Refining the clinical features and electrophysiological findings. Muscle & Nerve. PMID 26179421 DOI: 10.1002/Mus.24773 |
0.409 |
|
| 2015 |
Fan Z, Kocis K, Valley R, Howard J, Chopra M, Chen Y, An H, Lin W, Muenzer J, Powers W. High-pressure Transvenous Perfusion of the Upper Extremity in Human Muscular Dystrophy: A Safety Study with 0.9% Saline. Human Gene Therapy. PMID 25953425 DOI: 10.1089/Hum.2015.023 |
0.356 |
|
| 2015 |
Guptill JT, Yi JS, Sanders DB, Guidon AC, Juel VC, Massey JM, Howard JF, Scuderi F, Bartoccioni E, Evoli A, Weinhold KJ. Characterization of B cells in muscle-specific kinase antibody myasthenia gravis. Neurology® Neuroimmunology & Neuroinflammation. 2: e77. PMID 25745635 DOI: 10.1212/Nxi.0000000000000077 |
0.379 |
|
| 2015 |
Renton AE, Pliner HA, Provenzano C, Evoli A, Ricciardi R, Nalls MA, Marangi G, Abramzon Y, Arepalli S, Chong S, Hernandez DG, Johnson JO, Bartoccioni E, Scuderi F, Maestri M, ... ... Howard JF, et al. A genome-wide association study of myasthenia gravis. Jama Neurology. 72: 396-404. PMID 25643325 DOI: 10.1001/Jamaneurol.2014.4103 |
0.338 |
|
| 2014 |
Beltran Papsdorf TB, Howard JF, Chahin N. Pearls & Oy-sters: clues to the diagnosis of adult-onset acid maltase deficiency. Neurology. 82: e73-5. PMID 24590251 DOI: 10.1212/Wnl.0000000000000163 |
0.376 |
|
| 2013 |
Howard JF, Barohn RJ, Cutter GR, Freimer M, Juel VC, Mozaffar T, Mellion ML, Benatar MG, Farrugia ME, Wang JJ, Malhotra SS, Kissel JT. A randomized, double-blind, placebo-controlled phase II study of eculizumab in patients with refractory generalized myasthenia gravis. Muscle & Nerve. 48: 76-84. PMID 23512355 DOI: 10.1002/Mus.23839 |
0.311 |
|
| 2012 |
Kornegay JN, Childers MK, Bogan DJ, Bogan JR, Nghiem P, Wang J, Fan Z, Howard JF, Schatzberg SJ, Dow JL, Grange RW, Styner MA, Hoffman EP, Wagner KR. The paradox of muscle hypertrophy in muscular dystrophy. Physical Medicine and Rehabilitation Clinics of North America. 23: 149-72, xii. PMID 22239881 DOI: 10.1016/J.Pmr.2011.11.014 |
0.42 |
|
| 2012 |
Kornegay JN, Bogan JR, Bogan DJ, Childers MK, Li J, Nghiem P, Detwiler DA, Larsen CA, Grange RW, Bhavaraju-Sanka RK, Tou S, Keene BP, Howard JF, Wang J, Fan Z, et al. Canine models of Duchenne muscular dystrophy and their use in therapeutic strategies. Mammalian Genome : Official Journal of the International Mammalian Genome Society. 23: 85-108. PMID 22218699 DOI: 10.1007/S00335-011-9382-Y |
0.715 |
|
| 2012 |
Fan Z, Kocis K, Valley R, Howard JF, Chopra M, An H, Lin W, Muenzer J, Powers W. Safety and feasibility of high-pressure transvenous limb perfusion with 0.9% saline in human muscular dystrophy. Molecular Therapy : the Journal of the American Society of Gene Therapy. 20: 456-61. PMID 21772257 DOI: 10.1038/Mt.2011.137 |
0.389 |
|
| 2012 |
Howard J, Barohn R, Freimer M, Juel V, Mozaffar T, Mellion M, Benatar M, Farrugia M, Kissel J. Randomized, Double-Blind, Placebo-Controlled, Crossover, Multicenter, Phase II Study of Eculizumab in Patients with Refractory Generalized Myasthenia Gravis (gMG) (S35.004) Neurology. 78. DOI: 10.1212/Wnl.78.1_Meetingabstracts.S35.004 |
0.361 |
|
| 2010 |
Kornegay JN, Li J, Bogan JR, Bogan DJ, Chen C, Zheng H, Wang B, Qiao C, Howard JF, Xiao X. Widespread muscle expression of an AAV9 human mini-dystrophin vector after intravenous injection in neonatal dystrophin-deficient dogs. Molecular Therapy : the Journal of the American Society of Gene Therapy. 18: 1501-8. PMID 20517298 DOI: 10.1038/Mt.2010.94 |
0.407 |
|
| 2009 |
Donofrio PD, Berger A, Brannagan TH, Bromberg MB, Howard JF, Latov N, Quick A, Tandan R. Consensus statement: the use of intravenous immunoglobulin in the treatment of neuromuscular conditions report of the AANEM ad hoc committee. Muscle & Nerve. 40: 890-900. PMID 19768755 DOI: 10.1002/Mus.21433 |
0.319 |
|
| 2009 |
England JD, Gronseth GS, Franklin G, Carter GT, Kinsella LJ, Cohen JA, Asbury AK, Szigeti K, Lupski JR, Latov N, Lewis RA, Low PA, Fisher MA, Herrmann D, Howard JF, et al. Evaluation of distal symmetric polyneuropathy: the role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review). Muscle & Nerve. 39: 106-15. PMID 19086069 DOI: 10.1002/Mus.21227 |
0.309 |
|
| 2008 |
Howard JF, Sanders DB. Chapter 12 Neurotoxicology of neuromuscular transmission. Handbook of Clinical Neurology. 91: 369-400. PMID 18631850 DOI: 10.1016/S0072-9752(07)01512-6 |
0.327 |
|
| 2005 |
Galano HR, Olby NJ, Howard JF, Shelton GD. Myokymia and neuromyotonia in a cat. Journal of the American Veterinary Medical Association. 227: 1608-12, 1591. PMID 16313038 DOI: 10.2460/Javma.2005.227.1608 |
0.408 |
|
| 2001 |
Latov N, Chaudhry V, Koski CL, Lisak RP, Apatoff BR, Hahn AF, Howard JF. Use of intravenous gamma globulins in neuroimmunologic diseases. The Journal of Allergy and Clinical Immunology. 108: S126-32. PMID 11586280 DOI: 10.1067/Mai.2001.118300 |
0.369 |
|
| 2001 |
Navaneetham D, Penn AS, Howard JF, Conti-Fine BM. Human thymuses express incomplete sets of muscle acetylcholine receptor subunit transcripts that seldom include the delta subunit. Muscle & Nerve. 24: 203-10. PMID 11180203 DOI: 10.1002/1097-4598(200102)24:2<203::Aid-Mus50>3.0.Co;2-F |
0.321 |
|
| 2000 |
Wang ZY, Diethelm-Okita B, Okita DK, Kaminski HJ, Howard JF, Conti-Fine BM. T cell recognition of muscle acetylcholine receptor in ocular myasthenia gravis. Journal of Neuroimmunology. 108: 29-39. PMID 10900334 DOI: 10.1016/S0165-5728(00)00250-2 |
0.361 |
|
| 1998 |
Navaneetham D, Penn AS, Howard JF, Conti-Fine BM. TCR-Vbeta usage in the thymus and blood of myasthenia gravis patients. Journal of Autoimmunity. 11: 621-33. PMID 9878084 DOI: 10.1006/Jaut.1998.0246 |
0.334 |
|
| 1998 |
Howard JF. Intravenous immunoglobulin for the treatment of acquired myasthenia gravis. Neurology. 51: S30-6. PMID 9851728 DOI: 10.1212/Wnl.51.6_Suppl_5.S30 |
0.325 |
|
| 1998 |
Wang ZY, Okita DK, Howard J, Conti-Fine BM. T-cell recognition of muscle acetylcholine receptor subunits in generalized and ocular myasthenia gravis. Neurology. 50: 1045-54. PMID 9566393 DOI: 10.1212/Wnl.50.4.1045 |
0.389 |
|
| 1997 |
Patton LL, Howard JF. Myasthenia gravis: dental treatment considerations. Special Care in Dentistry : Official Publication of the American Association of Hospital Dentists, the Academy of Dentistry For the Handicapped, and the American Society For Geriatric Dentistry. 17: 25-32. PMID 9582706 DOI: 10.1111/J.1754-4505.1997.Tb00532.X |
0.374 |
|
| 1997 |
Wang ZY, Okita DK, Howard J, Conti-Fine BM. Th1 epitope repertoire on the alpha subunit of human muscle acetylcholine receptor in myasthenia gravis. Neurology. 48: 1643-53. PMID 9191781 DOI: 10.1212/Wnl.48.6.1643 |
0.322 |
|
| 1996 |
Jaradeh S, D'Cruz O, Howard JF, Haberkamp TJ, Konkol RJ. Mobius syndrome: electrophysiologic studies in seven cases. Muscle & Nerve. 19: 1148-53. PMID 8761272 DOI: 10.1002/(Sici)1097-4598(199609)19:9<1148::Aid-Mus11>3.0.Co;2-R |
0.385 |
|
| 1994 |
Howard JF, Sanders DB, Massey JM. The electrodiagnosis of myasthenia gravis and the Lambert-Eaton myasthenic syndrome. Neurologic Clinics. 12: 305-30. PMID 8041344 DOI: 10.1016/S0733-8619(18)30099-9 |
0.304 |
|
| 1994 |
Andrews PI, Massey JM, Howard JF, Sanders DB. Race, sex, and puberty influence onset, severity, and outcome in juvenile myasthenia gravis. Neurology. 44: 1208-14. PMID 8035917 DOI: 10.1212/Wnl.44.7.1208 |
0.305 |
|
| 1993 |
Manfredi AA, Protti MP, Dalton MW, Howard JF, Conti-Tronconi BM. T helper cell recognition of muscle acetylcholine receptor in myasthenia gravis. Epitopes on the gamma and delta subunits. The Journal of Clinical Investigation. 92: 1055-67. PMID 7688757 DOI: 10.1172/Jci116610 |
0.387 |
|
| 1993 |
Hopkins AL, Howard JF, Wheeler SJ, Kornegay JN. Stimulated single fibre electromyography in normal dogs Journal of Small Animal Practice. 34: 271-276. DOI: 10.1111/J.1748-5827.1993.Tb02685.X |
0.404 |
|
| 1992 |
Protti MP, Manfredi AA, Wu XD, Moiola L, Dalton MW, Howard JF, Conti-Tronconi BM. Myasthenia gravis. CD4+ T epitopes on the embryonic gamma subunit of human muscle acetylcholine receptor. The Journal of Clinical Investigation. 90: 1558-67. PMID 1383275 DOI: 10.1172/Jci116024 |
0.38 |
|
| 1991 |
Protti MP, Manfredi AA, Howard JF, Conti-Tronconi BM. T cells in myasthenia gravis specific for embryonic acetylcholine receptor. Neurology. 41: 1809-14. PMID 1682852 DOI: 10.1212/Wnl.41.11.1809 |
0.418 |
|
| 1989 |
Massey JM, Sanders DB, Howard JF. The effect of cholinesterase inhibitors of SFEMG in myasthenia gravis. Muscle & Nerve. 12: 154-5. PMID 2540433 DOI: 10.1002/Mus.880120211 |
0.326 |
|
| 1988 |
Sanders DB, Howard JF. Thymoma without myasthenia gravis: electrophysiological study after thymectomy. Journal of Neurology, Neurosurgery, and Psychiatry. 51: 160-1. PMID 3351526 DOI: 10.1136/Jnnp.51.1.160-A |
0.308 |
|
| 1986 |
Sanders DB, Howard JF. AAEE minimonograph #25: Single-fiber electromyography in myasthenia gravis. Muscle & Nerve. 9: 809-19. PMID 3785290 DOI: 10.1002/Mus.880090904 |
0.497 |
|
| 1981 |
Sanders DB, Kim YI, Howard JF, Johns TR, Muller WH. Intercostal muscle biopsy studies in myasthenia gravis: clinical correlations and the direct effects of drugs and myasthenic serum. Annals of the New York Academy of Sciences. 377: 544-66. PMID 6280565 DOI: 10.1111/J.1749-6632.1981.Tb33758.X |
0.733 |
|
| 1980 |
Howard JF, Sanders DB. Passive transfer of human myasthenia gravis to rats: 1. Electrophysiology of the developing neuromuscular block. Neurology. 30: 760-4. PMID 7190241 DOI: 10.1212/Wnl.30.7.760 |
0.353 |
|
| 1980 |
Sanders DB, Kim YI, Howard JF, Goetsch CA. Eaton-Lambert syndrome: a clinical and electrophysiological study of a patient treated with 4-aminopyridine. Journal of Neurology, Neurosurgery, and Psychiatry. 43: 978-85. PMID 6255102 DOI: 10.1136/Jnnp.43.11.978 |
0.382 |
|
| 1979 |
Sanders DB, Howard JF, Johns TR. Single-fiber electromyography in myasthenia gravis. Neurology. 29: 68-76. PMID 218146 DOI: 10.1212/Wnl.29.1.68 |
0.723 |
|
| Show low-probability matches. |